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Abstract
Background There is little knowledge about how patients perceive
and react to the extended role of community pharmacies.
Aim To develop a model describing the expanded role of Portu-
guese community pharmacies as comprising three roles – medicines
supplier, advice provider and community health promoter – and
two important patient reactions: satisfaction and loyalty.
Design In 2010, 1200 face-to-face interviews were conducted with
patients of community pharmacies in Portugal. A model compris-
ing the three pharmacy roles and the two patient reactions was
developed and tested using structural equation modelling.
Results The results showed that the model was appropriate and
that the roles of medicines supplier, advice provider and commu-
nity health promoter were positively related to patients’ satisfac-
tion and loyalty.
Conclusions These results show that patients are aware of the dif-
ferent roles played by community pharmacies in Portugal. The
data support the idea that the movement of Portuguese pharma-
cists’ extended role, framed within a global context where society
sends expectations regarding the role of organizations in the com-
munity in which they operate, is producing positive results for
both patients and pharmacists.
Introduction
In Portugal as in other Western countries, the
role of community pharmacies is changing
from being solely a place where patients can
acquire medicines or other health and welfare-
related products, to being somewhere where
patients can obtain individual health advice
and specialized care. The changing role of
pharmacists and pharmacies is being advocated
by institutions such as the World Health
Organization1,2 and in Portugal by representa-
tives of pharmacists3 and pharmacies.4 As
noted by Zeind and McCloskey,5 “pharmacists
have expanded their roles in practice settings
and now serve as integral members of an inter-
disciplinary health-care system. It will now be
important to determine how the public will
respond to a more patient-centred pharmacy
practice” (p. 153, emphasis added). Most of
studies that examined patients’ reactions to the
extended role of community pharmacists show
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a positive effect of the roles of pharmacists in
medication/therapeutic management and pati-
ent counselling6 but none have analysed how
patients react to the pharmacy’s general com-
munity orientation. In this study, we draw on
corporate social responsibility (CSR) literature
to develop an integrated model describing the
expanding roles of Portuguese community
pharmacies – three roles – medicines supplier,
advice provider and community health pro-
moter – and their relationships to patient satis-
faction and loyalty. Framing pharmacies’
activity as roles played in society led us to
focus our analysis on the outcomes for
patients. By doing this, we are contributing
to knowledge about the social role played
by community pharmacies, which is relevant
considering that CSR has not received system-
atic attention in the health-care literature.7
Although there have been some studies investi-
gating the dimensions of patient satisfaction
with pharmaceutical care in the community8,9
and a validated instrument has been developed
to measure this,10,11 we are not aware of other
studies that conceptualize community phar-
macy roles in the way that we propose, or that
take into account these recent developments in
professional roles.
From medicines supplier to advice provider
Community pharmacies are multidimensional
entities. On one hand, they are businesses whose
viability depends on a market that allows them
to earn necessary revenue. As they often operate
in highly competitive contexts, customer satis-
faction and loyalty are key factors if they are to
be economically viable. Pharmacies are also
places of work, where pharmacists play their
professional role, which is increasingly focused
on patients as individuals and which can also
generate favourable reactions from pharmacy
patients. The extended role of community phar-
macies is a natural consequence of the move-
ment to reprofessionalize pharmacists who, by
emphasizing the provision of patient care, aim
to enhance the status of their profession12 and
promote professional flexibility.13 This new role
broadens the scope of pharmaceutical practice,
adding the role of information and patient care
provider to the traditional one of medicines sup-
plier,14 a role designated as advice provider in
this study. Pharmacy patients potentially benefit
from a wider range of services often at a lower
cost and with more convenience than visiting
their doctor and experiencing this may lead to
satisfaction with and loyalty to a particular
pharmacy.
Only a few studies have investigated how
pharmacy users perceive pharmacies’ roles and
react to changes in these roles. Research shows,
despite a positive overall assessment of a com-
munity pharmacy medicines management ser-
vice in which they were involved,15 certain
patients do not see pharmacists’ recommenda-
tions as sufficiently legitimate, placing their trust
rather in general practitioners in relation to deci-
sions regarding managing their treatment.16
Similarly, results point to a partial resistance or
ambivalent attitudes to advice obtained from
not only community pharmacies17,18 but also
hospital pharmacies.19 Public and other health-
care providers’ perceptions about pharmacists’
competencies, among other factors, can reduce
more generalized utilization of pharmacy ser-
vices.20 As levels of advice can be different,
depending on the specific pharmacy where it is
given, it becomes important to examine to what
extent it is related to pharmacy patient criteria.
Considering the critical influence of trust in
health-care professionals in the effectiveness of
care,21–23 we can hypothesize that increased lev-
els of trust in pharmacists’ advice results in
higher customer satisfaction and loyalty. How-
ever, this supposition does not negate the influ-
ence of the more traditional role reserved for the
community pharmacy (medicines supplier) in
relation to customer satisfaction and loyalty,
but rather suggests that these results are also
affected by the advice provider role.
Adding the community health promoter role
In addition to the roles of medicines supplier
and advice provider, we suggest in this study
that Portuguese pharmacies play an additional
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role that of community health promoter. Phar-
macies have a social role, with responsibilities
for promoting public health and maximizing
social cohesion. Due to their proximity and
easy access, pharmacies are often the first port
of call for the relief of less serious symptoms
and increasingly places where patients can get
specialized care. In Portugal, pharmacies often
participate in programmes for the identification
and control of several common illnesses, pro-
grammes for the free exchange of syringes for
drug addicts, pharmaceutical care programmes,
chronic disease prevention campaigns, inte-
grated waste management of packaging and
out-of-date medicines, charity support projects
and interest-free credit to buy medicines.24
Considering this possible level of involve-
ment of pharmacies in the community, express-
ing themselves as social actors,25 we propose
that pharmacies have a third important role in
addition to those of medicines supplier and
advice provider, namely the community health
promoter. The literature on corporate social
responsibility (CSR) is helpful in understanding
this role. Regardless of the controversy sur-
rounding the definition of CSR26 and the mul-
tiple interpretations of this concept that have
been produced,27,28 CSR can be seen as a legit-
imizing practice in contemporary organiza-
tions,29 meaning that organizations go beyond
the immediate objectives of creating profit to
create legitimacy and benefits30 via positive
community activities.
In line with this vision of CSR and the wide-
spread evidence that CSR activities have the
potential to generate stronger relationships
between companies and customers, positive
firm evaluations and loyalty,31 we propose that
the extent to which the pharmacy is involved
in the community and acts as a promoter of
community health is related to the satisfaction
and loyalty of its patients. This assumption
only holds if community involvement is related
to the roles of medicines supplier and advice
provider. The next section will provide addi-
tional support for this argument.
Integrating the three pharmacy roles and
predicting their relationship with satisfaction
and loyalty
To integrate pharmacies’ roles and the relation-
ship with patients’ satisfaction and loyalty, we
developed the model depicted in Fig. 1. The
model shows pharmacies as expanding their
roles from medicines dispenser to advice pro-
vider and to community health promoter.
Additionally, this model was based on two
major contributions: the distinction between
corporate ability (CA) and corporate social
responsibility (CSR);32 efforts made to describe
responses of customers to companies’ social
responsibility projects.33
Corporate ability (CA) describes an organi-
zation’s ability to generate products and ser-
vices and corporate social responsibility (CSR)
represents how committed organizations are to
their social obligations.32 CA and CSR may
have different effects on consumer responses
regarding these initiatives. Research aimed to
Figure 1 A model of community
pharmacies’ roles.
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determine whether CSR and CA can compen-
sate for each other found that, in relation to
product preference, poor CA is not compen-
sated by good CSR, especially if consumers
believe that the CA is an important factor;
however, reduced CRS can be compensated by
a good CA.33
In the case of the operations of pharmacies
in the community, we suggest that their
essential output (their CA) is that of medi-
cines supplier. CSR initiatives reflect their
role as community health promoters. The
advice provider role is currently emerging
and it is not clear whether it should be
considered a dimension of CA or CSR. We
are not aware of any research investigating
CSR and its relationships with satisfaction
and loyalty. However, in the future, with the
widespread adoption and incorporation of the
advice provider role into customer expecta-
tions of normal service from community
pharmacies, it seems most likely that this role
will become part of CA.
In modelling the impact of CSR projects
on consumers’ reactions, Bhattacharya and
Sen’s34 framework provides an appropriate
reference tool. They developed a contingency
model to distinguish internal outcomes, such
as awareness of and attitudes towards the
company from external, or visible, outcomes,
which include purchase behaviour, word of
mouth and loyalty. Although there is vari-
ability in consumer responses to CSR activ-
ity, research shows that CSR has much
greater impact on internal outcomes than
external ones.34
In short, based on the distinction between
CA and CSR and the model of consumer
responses to social responsibility activities, we
predict a significant positive relationship
between the three roles of community phar-
macies – medicines supplier, advice provider
and community health promoter – and two
important results – satisfaction with and loy-
alty to the pharmacy. The aim of this study
was to test this set of relationships in a sam-
ple of Portuguese customers of community
pharmacies.
Methods
Sample and procedure
The sample was composed of 1200 patients.
Sampling followed a two-stage procedure. Dur-
ing the first stage, eight districts from a total of
18 on the Portuguese mainland were randomly
selected (excluding the autonomous regions of
Madeira and the Azores). Selected districts rep-
resent 60% of total pharmacies registered in
Portugal (2817 in 201035) and 50% of total
residing population (10 562 17836). Then, 30
pharmacies were randomly selected from the
eight districts, considering the number of exist-
ing pharmacies. Permission was sought from
owners to approach patients off-site immediately
after being served at the respective pharmacy.
For 2 days a week in April 2010, following a
plan of a random selection of 40 patients per
pharmacy, patients were approached by a
trained interviewer, who invited them to partic-
ipate in a study about the pharmacy. The take-
up rate for the study was very high (84.5% of
those approached agreed to participate). Data
collection took place through personal and
direct interviews, using A4 cards with the scales
employed. The option for this type of data col-
lection was based on the premise that phar-
macy patients are older than the national
average and some may have some difficulty
with self-administered questionnaires. Accord-
ing to regulations in Portugal, approval from
an ethical committee was not required to con-
duct the study. Data were analysed using IBM
SPSS 19 (IBM SPSS, 19.0. Armonk, NY: IBM
Corp. USA) and MPLUS 6.12 (MPLUS 6.12,
Muthe´n & Muthe´n, Los Angeles, USA). The
data on respondents’ socio-demographic profile
and pharmacy use can be found in Table 1.
Measures
To test the relationship between the pharmacy
roles and patient results, we used a combina-
tion of existing measures and ones created spe-
cifically for this study. We have developed the
measures for the medicines supplier and advice
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provider roles. Using an inductive approach,37
we conducted 16 semi-structured interviews
with patients (n = 10) and pharmacists (n = 6),
with the answers subject to content analysis
with a set of illustrative quotations from
exploratory interviews. Using this result as a
basis, we drafted two sets of 10 and 19 items
to measure, respectively, the medicines supplier
and advice provider roles.
To measure the medicines supplier role, we
asked respondents to assess the pharmacy
according to a scale ranging from 1 (very poor)
to 5 (very good). After examining missing
values, exploratory and confirmatory factor
analysis and calculation of item-test correla-
tions, four items were retained. This measure
had good levels of reliability (a = 0.76).
In relation to the pharmacy’s role as advice
provider, respondents were asked to focus
their attention on staff at the pharmacy that
served them most often and rate the domi-
nant behaviour with a 5-point scale ranging
from 1 (strongly disagree) to 5 (strongly
agree). The initial set of 19 items was sub-
jected to exploratory factor analysis, a proce-
dure which, after deleting five items due to
saturation greater than 0.50 in more than
one dimension, showed that there were three
factors with eigenvalues greater than 1. For
this study, the first factor was retained, which
explained 34.0% of variance. This factor was
chosen on the basis that it contained items
related to trust in the advice obtained from
the pharmacy. Confirmatory factor analysis
led us to retain four items. Reliability of this
scale was high (a = 0.86).
To measure the community health promoter
role, an adapted version of an already existing
scale was used.38 Originally created to assess
reputation with six items the scale was clearly
focused on the organization’s contribution to
the community, which is appropriate for this
study. Moreover, the joint development and
potential methodological overlap of corporate
social performance and corporate reputation
was already higlighted.39 The adapted scale
was reduced to four items following item
analysis and has already been used in Portu-
gal.40 This measure is based on a 5-point rating
scale, ranging from 1 (strongly disagree) to 5
(strongly agree). The reliability of the scale was
high (a = 0.85).
We measured satisfaction using four of the
five items of a widely internationally used scale
in retail selling.41 This scale is made up of five
items measured via a 7-point semantic differen-
tial, asking respondents to express their satis-
faction with their buying experience. After item
analysis, we eliminated one of these items due
to clear redundancy when compared to the
others. The reliability of the scale was very
high (a = 0.91).
Table 1 Sample description
Time taken to get to pharmacy (min) M = 8.62 (SD = 7.30)
Age (years) M = 60.60 (SD = 17.39)
%
Sex
Male 35.5
Female 64.5
Job situation
Unemployed 7.4
Student 3.0
Self-employed 11.2
Employee 35.4
Retired 32.9
Housewife/husband 10.1
Education
Illiterate/incomplete primary education 12.3
Primary education 29.5
1st cycle 12.2
9th year 18.8
12th year 14.3
Higher education 12.8
Did not respond 0.2
No. of trips to the pharmacy in the last 6 months
Never 0.1
1–3 times 16.3
4–6 times 30.4
7–10 times 8.0
11 or more times 45.3
No. of requests for advice from pharmacist
in the last 6 months
None 19.8
1–3 52.7
4–6 20.3
7–10 3.8
11 3.6
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Patient loyalty to the pharmacy was mea-
sured using four items taken from a scale of
consumer commitment.42 Although this con-
cept tends to be seen as multidimensional, we
used a one-dimensional measure that had
already been used in Portugal24 and which cov-
ers the main aspects of loyalty, such as the
intention to remain a customer of the phar-
macy or recommending it to friends. Respon-
dents answer on a 5-point rating scale
(1 = strongly disagree and 5 = strongly agree).
The reliability of this scale was good
(a = 0.77).
To check common method variance, a mar-
ker variable43 in the guise of the following
question was used: ‘Overall, how satisfied are
you with the service provided by public hospi-
tals in Portugal’. This was measured on a scale
of 1–5, from not at all satisfied to very satis-
fied. The significance level used in this study
was 0.05.
Analysis strategy
Given the categorical nature of the response set,
we based our analysis on the polychoric correla-
tion matrix and deployed the weighted least
squares (WLSMV) estimator. Indeed, assess-
ment of normality revealed a severe multivari-
ate kurtosis (Mardia coefficient = 201.25). The
WLSMV is a robust estimator which does not
assume normally distributed variables and pro-
vides the best option for modelling categorical
or ordinal data.44,45 Initially, confirmatory fac-
tor analysis was performed to test the robustness
of our proposed measurement model composed
of five factors over an alternative measurement
model composed of one latent variable deter-
mined by all observed variables. As values from
the chi-squared test relative to the degrees of
freedom are inflated by large sample sizes and
this ratio is not recommended for categorical
data46 criteria to evaluate the model fit also
included the comparative fit index (CFI), the
Tucker–Lewis, the root mean square error of
approximation (RMSEA) and weighted root
mean square residual (WRMR), a promising
experimental fit statistic for non-normal ordered
categorical data that substitutes the standard-
ized root mean square residual44. Table 3 shows
the final results for the measurement model.
Results
The means, standard deviations, reliabilities
and correlations among variables studied are
presented in Table 2. Correlations were moder-
ate but did not exceed 0.60, with one exception
(advice provider – community health promoter,
r = 0.66). This indicates an acceptable degree
of multicollinearity.47
The correlations between marker variable
and the other variables were between 0.02
and 0.11, coefficients that are sufficiently low
for us to consider the common method effect
to be negligible. The average values for the
variables studied were high, but this trend
corroborates other studies on pharmacy
patients.48 As the marker variable had a sub-
stantially lower average level, we can consider
that the general attitude of patients towards
the pharmacy is very positive.
The results of the measurement model test
showed that the five factor model presented
Table 2 Means, standard deviations, intercorrelations, and reliabilities
Mean SD 1 2 3 4 5 6
1. Medicines supplier 4.23 0.51 (0.76)
2. Advice provider 4.31 0.52 0.57** (0.86)
3. Community health promoter 4.24 0.53 0.57** 0.66** (0.85)
4. Satisfaction 6.54 0.63 0.48** 0.50** 0.50** (0.91)
5. Loyalty 4.13 0.77 0.49** 0.59** 0.56** 0.48** (0.77)
6. Satisfaction with public hospitals*** 3.72 0.80 0.09* 0.11** 0.09* 0.05 0.02 –
N = 1200; *P < 0.05; **P < 0.01; ***marker variable. All variables were measured on a scale of 1–5, with the exception of satisfaction with
pharmacy, which were measured on a scale of 1–7.
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acceptable fit (v2 = 607.55, d.f. = 160,
P < 0.0001; CFI = 0.99; TLI = 0.99; RMSEA =
0.05; WRMR = 1.04), whereas the same did not
occur for the single factor model (v2 = 4700.03,
d.f. = 170, P < 0.0001; CFI = 0.94; TLI = 0.94;
RMSEA = 0.15; WRMR = 4.50). Indicators of
convergent validity surpassed recommended
thresholds49 (Composite reliability >0.70 and
average variance extracted >0.50).
Fit indices for the structural model were
acceptable (v2 = 607.55, d.f. = 160, P < 0.0001;
CFI = 0.99; TLI = 0.99; RMSEA = 0.05;
WRMR = 1.04). Estimated regression coeffi-
cients are given in Table 4. The standardized
regression coefficients and explained variance
for satisfaction and loyalty are included in
Fig. 2. These show that the assessment of
roles played by pharmacies explained 50% of
patients’ satisfaction with pharmacies and
61% of patients’ loyalty to these entities. All the
relationships between pharmacies’ roles and
patients’ reactions were in the expected posi-
tive direction. More precisely, the medicines
supplier role was more related to satisfaction
Table 3 Measurement model
Observed variable Latent construct B b AVE CR
How do you assess the pharmacy regarding. . .(scale 1–5) Medicines supplier
The availability of drugs/that I need 1.00 0.76
The pharmacy’s opening hours in relation to my needs 1.13 0.85
The pharmacy’ appearance and decoration 1.09 0.82 0.58 0.84
The availability of waiting space (If needed) 0.72 0.59
Thinking about pharmacy’ staff who serve you most often
(scale 1–5)
Advice provider
I feel I can trust the advice I receive from this pharmacy 1.00 0.85
I find the necessary competence to be advised on how
to improve my health
1.03 0.87 0.75 0.93
I feel I can trust in pharmaceutical advice 1.05 0.89
I feel at easy to talk with pharmaceutics about my
health problems
1.01 0.86
Generally speaking about this pharmacy (scale 1–5) Community health
promoter
I believe that this pharm. benefits the community/place
where it operates
1.00 0.89
We can say this pharm. has a good reputation in the
community
0.88 0.79 0.74 0.92
Has a good reputation among its costumers 1.02 0.91
This pharmacy is actively involved in the community 0.94 0.84
How do you feel about this pharmacy? (scale 1–7) Satisfaction
Dissatisfied–Satisfied 1.00 0.95
Unpleased–Pleased 1.00 0.95 0.89 0.97
Good–Bad 1.02 0.93
Unhappy–Happy 1.02 0.95
Considering the relationship you have with this pharmacy
. . .(scale 1–5)
Loyalty
Even knowing that other pharm. offer better conditions,
I’ll still be a costumer
1.00 0.80
I would not recommend this pharmacy to a friend
(reversed)
1.07 0.86 0.59 0.85
I would defend this pharmacy if other people criticized it 0.74 0.59
I feel a certain moral obligation to remain a costumer of
this pharmacy
0.99 0.80
B, regression estimate; b, standardized regression estimate; AVE, average variance extracted; CR, composite reliability.
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than loyalty, advice provider role was more
related to loyalty than satisfaction, and commu-
nity health promoter role was equally related to
satisfaction and loyalty. Generally, the results
supported the suggested model describing
pharmacies’ integrated roles in expansion and
positive relationship between these roles and
satisfaction and loyalty.
Discussion
Following the trend observed in many western
societies, Portuguese community pharmacists
are adopting an extended role, adding the role
of advice provider to the more traditional one
of medicines supplier. As social actors, and to
the extent that they are strongly embedded in
the community, Portuguese pharmacies also ful-
fil a role as a promoter of community health,
which is an expression of their social responsi-
bility. If this expanded role is being taken up by
pharmacists and increasingly recognized by the
various relevant institutions in this field (WHO,
the Pharmacists Association, the National
Association of Pharmacies), its impact on
patients is still relatively unknown. Our results
show that, in Portugal, community pharmacies
can be seen as economic and social agents that
play three complementary roles (medicines sup-
pliers, advice providers and community health
promoters) and that these roles are positively
related to both pharmacy customer satisfaction
and loyalty, but more strongly to loyalty.
If satisfaction can be seen in a more human-
istic way,50 in that it relates to customer wel-
fare, loyalty can have a more strategic sense, as
it clearly precedes increases in revenue. It is
worth noting that these results are consistent
with CSR perspectives that highlight the need
for organizations to satisfy the interests of
multiple stakeholders, and it is not uncommon
for initiatives of this nature to have a positive
impact on organizational results.30,51 These
results are relevant for community pharmacies
as they point to the need to develop an inte-
grated strategy stressing, simultaneously, the
three roles and making sure they are noticed
by patients. Optimizing the supply chain and
Table 4 Estimated regression coefficients for the structural
equation model
Relationship under examination B P-value SE
Medicines supplier – Satisfaction 0.41 0.00 0.06
Advice provider – Satisfaction 0.27 0.00 0.07
Community health promoter –
Satisfaction
0.22 0.00 0.06
Medicines supplier – Loyalty 0.14 0.00 0.04
Advice provider – Loyalty 0.44 0.00 0.04
Community health promoter – Loyalty 0.21 0.00 0.04
Satisfaction–Loyalty 0.06 0.00 0.02
N = 1200 patients; B, standardized regression estimates; P-value is
two tailed; SE, standard errors.
Figure 2 The relationship between pharmacies’ roles and patients’ satisfaction and loyalty.
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the physical pharmacies’ characteristics are
possible ways to improve the medicines pro-
vider role, and, by doing this, mainly increas-
ing patient satisfaction. Continuous training to
develop both technical and interpersonal skills
may assist to maintain or raise the level of
advice provider role, probably contributing
mainly to loyalty. Engaging in community ori-
ented activities, supplying syringes for drug
addicts, integrated waste management of pack-
aging and out-of-date medicines, interest-free
credit to buy medicines, training young
people in schools on how to adopt healthier
behaviours and effectively communicating these
activities, are among the possibilities to
improve the community health promoter role
and, possibly, generate more satisfaction and
loyalty among patients.
Although studies have generally found that
pharmacists’ non-dispensing roles have a posi-
tive effect on patient clinical outcomes and pre-
scribing patterns,6 there are fewer studies that
investigate outcomes such as satisfaction and
loyalty. Research shows that satisfaction with
community pharmacies was related to relation-
ship factors, general competence and pharmacy
atmosphere,52 whereas in ambulatory care
research found that satisfaction was related to
three factors – general staff communication,
medication-focused communication and the
clarity of written information.53 Clearly some
aspects of these findings overlap with those of
the current study (e.g. general competence and
communication could relate to any of our
dimensions) but are not completely congruent.
Our approach, driven by a theoretical frame-
work and a perspective that emphasizes evolving
professional roles, was to investigate perceptions
of roles undertaken by community pharmacists
in contrast to examining generic features such as
atmosphere or communication.
In common with other areas of health care,54
the lack of theoretical frameworks to under-
stand satisfaction is a factor that has limited
the field.50,55 In this study, we have provided
evidence about public reactions to the changing
roles of community pharmacies and have built
and tested a model that integrated how
patients perceive and react to these changes.
We used theory to distinguish three roles of
community pharmacies and applied the CSR
framework to examine how these roles affect
customer satisfaction and loyalty. Both corpo-
rate ability and social responsibility are
important dimensions in assessing the role
pharmacies play in society. The model we
developed was a fruitful approach and led to
further insights into the relationships between
satisfaction, loyalty, pharmacy roles and
patients’ characteristics. Patients perceive phar-
macies via multiple dimensions and these con-
tribute in different ways to levels of satisfaction
and loyalty.
The results of this study support and extend
the results of studies of patient satisfaction in
community pharmacy and in other health-care
settings. Studies of patient satisfaction in pri-
mary care have found that service quality is pos-
itively related to patient satisfaction56 and that
trust and good interpersonal relationships with
the health-care provider predicted satisfaction
and loyalty.57,58 In cancer care, service quality
was positively related to patient willingness to
recommend the service.59 Our results are in
broad agreement, but provide deeper under-
standing by examining separately three major
roles played by community pharmacies. Current
approaches to understanding patient satisfaction
focus on aspects of the interpersonal relation-
ship with the clinician, but a different approach
could be taken by examining the influence of
perceptions of different roles, such as perform-
ing clinical procedures, providing advice and
providing emotional support. Looking at
healthcare organizations as entities playing roles
in society can give a distinct understanding of
factors underlying patients’ reactions to health-
care providers.
A potential limitation of this study is the
validity of the three measures of pharmacy roles.
In response to this limitation, one of the avenues
of future theoretical and methodological devel-
opment could be to further develop these scales
and investigate and improve their psychometric
properties.53 Additionally, future research could
determine the impact of the different roles on
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patient reactions other than satisfaction and
loyalty, such as awareness of the cause or attri-
bution of causes of organizational activity, the
variation of which could be the subject of
further research. On the other hand, moderators
of the relationship between CSR activities and
internal outcomes and between internal and
external outcomes could be examined. Future
research could test more complex models than
the one tested here, including several mediation
and moderation relationships. External validity
of the model could also be gained, by examining
data from other countries.
In conclusion, this study supports the idea
that the expansion of Portuguese pharmacists’
role, in line with the global trend for pharma-
cists to move from a focus on providing, dis-
pensing and prescription checking service to a
public health role, framed within a context of
social expectations regarding organizations’
community involvement, is generating favour-
able results for patients and pharmacists.
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